CEACAM3 Antibodies

Santa Cruz Biotechnology delivers a wide array of CEACAM3 monoclonal antibodies for research focused on understanding this important protein. CEACAM3 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEACAM3, a member of the carcinoembryonic antigen (CEA) family, plays a crucial role in immune response and cell adhesion. CEACAM3 is primarily expressed in leukocytes and regulates immune cell interactions, making it significant for studying infections and immune disorders. Research has shown that CEACAM3 expression patterns vary across different cell types and physiological conditions. Understanding CEACAM3 function and regulation can reveal new therapeutic strategies for immune-related diseases. Investigating CEACAM3 signaling pathways provides valuable insights into cellular communication mechanisms. Current research highlights CEACAM3's potential as a therapeutic target in various diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CEACAM3 and its impact on human health.